Clinical Trial
| Eli Lilly CGAT | |
| Therapeutic Area Name | Pediatrics |
| Condition or Disease | Pediatric Migraine |
| Title | A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age with Chronic Migraine |
| Study ID | Eli Lilly CGAT |
| Principal Investigator First Name | Abdul |
| Principal Investigator Last Name | Mazin |
| Clinicaltrials.gov | NCT04616326 |